Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

NCT06270433 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Anhedonia

Interventions

DRUG: Toludesvenlafaxine hydrochloride sustained-release tablets
DRUG: Desvenlafaxine succinate sustained-release tablets

Sponsor

Jiangsu Province Nanjing Brain Hospital